Clair Health Funding: How Much Did They Raise & Key Investors

How Much Did Clair Health Raise?
Funding & Key Investors

Clair Health has successfully secured a significant capital injection, bringing its total funding to $11.6M. This latest financing round, which includes a $11.6M strategic investment, underscores the growing market confidence in the company's innovative approach to reproductive and hormonal health monitoring. By leveraging advanced biosensing technology, the firm is positioning itself as a leader in the rapidly expanding femtech sector, providing users with actionable data that was previously only accessible through clinical laboratory environments.

The recent infusion of capital marks a pivotal moment for the organization as it transitions from early-stage development to a more robust operational phase. This backing from prominent venture firms highlights the scalability of their jewelry-inspired wearable platform and the potential for widespread adoption in both consumer and enterprise health markets.

What is Clair Health?

Clair Health

Manufacturing

Medical Devices & Equipment

Clair Health operates at the intersection of wearable technology and endocrinology, offering a sophisticated wristband designed to monitor hormonal fluctuations in real-time. Unlike traditional diagnostic methods that require invasive blood draws or urine samples, the company utilizes noninvasive biosensors to track estrogen, progesterone, LH, and FSH levels. This technological breakthrough allows for continuous data collection, enabling users to gain deep insights into their fertility, fitness, and menopausal health. By decoding complex hormonal patterns, Clair Health provides a seamless, user-centric solution that bridges the gap between personal wellness tracking and clinical-grade health diagnostics.

How much funding has Clair Health raised?

Clair Health has raised a total of $11.6M across 1 funding round:

2026

Seed

$11.6M

Seed (2026): $11.6M with participation from AGI House and Khosla Ventures

Key Investors in Clair Health

AGI House

AGI House is a community and venture fund dedicated to empowering AI founders and researchers to accelerate humanity's transition to Artificial General Intelligence.

Khosla Ventures

Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies across health, AI, and sustainable energy sectors.

What's next for Clair Health?

With the recent capital secured, Clair Health is well-positioned to accelerate its product roadmap and expand its market reach. The strategic focus will likely center on refining its proprietary biosensor algorithms and scaling manufacturing capabilities to meet anticipated consumer demand. Furthermore, the company is expected to explore partnerships with healthcare providers and enterprise wellness programs, integrating its hormonal insights into broader digital health ecosystems. As the firm continues to iterate on its hardware and software stack, it remains focused on establishing a new standard for proactive, data-driven hormonal health management, ultimately empowering users with the information necessary to make informed decisions about their physiological well-being.

See full Clair Health company page

See More Financial Insights